Abstract:Hyperglycaemia is a characteristic of type 2 diabetes. In hepatocytes, impaired insulin sensitivity leads to increased gluconeogenesis and decreased glycogenesis. MicroRNA (miR)‑338‑3p is associated with tumour necrosis factor (TNF)‑α‑induced suppression of hepatic glycogenesis via regulation of protein phosphatase 4 regulatory subunit 1 (PP4R1). However, the effect of miR‑338‑3p on gluconeogenesis in hepatocytes remains unknown. In a previous study, it was demonstrated that miR‑338‑3p is downregulated in the livers of mice and in mouse HEPA1‑6 hepatocytes following treatment with TNF‑α. In the present study, the effect of miR‑338‑3p on TNF‑α‑induced gluconeogenesis in hepatocytes was investigated. The levels of phosphorylated‑FOXO1/FOXO1, phosphoenolpyruvate carboxykinase (PEPCK), peroxisome proliferator‑activated receptor γ coactivator (PGC‑1α) and glucose‑6‑phosphatase (G6Pase) were measured by western blotting. The mRNA levels of PEPCK, PGC‑1α and G6Pase were determined by quantitative polymerase chain reaction. Pyruvate tolerance testing was used to determine the gluconeogenesis of mouse livers. The results demonstrated that treatment with TNF‑α resulted in increased levels of gluconeogenesis in the livers of mice and decreased miR‑338‑3p expression levels in HEPA1‑6 cells. Overexpression of miR‑338‑3p reversed TNF‑α‑induced glucose production via enhancement of phosphorylated forkhead box O1 levels and downregulation of the expression levels of genes associated with gluconeogenesis, including peroxisome proliferator‑activated receptor γ coactivator‑1α, phosphoenolpyruvate carboxykinase and glucose‑6‑phosphatase. However, inhibition of miR‑338‑3p expression was revealed to enhance gluconeogenesis in the livers of mice and in HEPA1‑6 cells. Furthermore, downregulation of PP4R1 was revealed to attenuate the effect on glucose production following treatment with miR‑338‑3p inhibitors. In conclusion, the results of the present study revealed that miR‑338‑3p may be involved in TNF‑α‑mediated gluconeogenesis via targeting of PP4R1 in hepatocytes.

Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling

Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting P65 to Upregulate PTEN Expression

[Mir-494-3p Reduces Insulin Sensitivity in Diabetic Cardiomyocytes by Down-Regulation of Insulin Receptor Substrate 1].

MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase

Circulating Mir-143-3p Inhibition Protects Against Insulin Resistance in Metabolic Syndrome Via Targeting of the Insulin-Like Growth Factor 2 Receptor.

Mir-338-3p Mediates Tnf-A-Induced Hepatic Insulin Resistance by Targeting Pp4r1 to Regulate Pp4 Expression

Hepatic miR‐125b inhibits insulin signaling pathway by targeting PIK3CD

A Novel Function of MicroRNA 130A-3P in Hepatic Insulin Sensitivity and Liver Steatosis

PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response.

Upregulation of Mir-181A Impairs Hepatic Glucose and Lipid Homeostasis.

Identification of microRNA that represses IRS-1 expression in liver

Mir199a-5P Inhibits Hepatic Insulin Sensitivity Via Suppression of ATG14-mediated Autophagy

MicroRNA 152 Regulates Hepatic Glycogenesis by Targeting PTEN.

MicroRNA-27a/b Negatively Regulates Hepatic Gluconeogenesis by Targeting FOXO1.

MicroRNA-29 Fine-tunes the Expression of Key FOXA2-Activated Lipid Metabolism Genes and Is Dysregulated in Animal Models of Insulin Resistance and Diabetes

Identification of two microRNA nodes as potential cooperative modulators of liver metabolism

HNF-4α Regulated Mir-122 Contributes to Development of Gluconeogenesis and Lipid Metabolism Disorders in Type 2 Diabetic Mice and in Palmitate-Treated HepG2 Cells

Mir-140-5p Aggravates Insulin Resistance Via Directly Targeting GYS1 and PPP1CC in Insulin-Resistant HepG2 Cells.

MicroRNA‐30b Regulates Insulin Sensitivity by Targeting SERCA2b in Non‐alcoholic Fatty Liver Disease

Mir‑338‑3p Mediates Gluconeogenesis Via Targeting of PP4R1 in Hepatocytes.

Microrna-20a-5p Contributes to Hepatic Glycogen Synthesis Through Targeting P63 to Regulate P53 and Pten Expression